Fact CheckerSign in

NCT06938074Not yet recruiting

Imaging and Treatment Planning for Cardiac Radioablation

Source: ClinicalTrials.gov · Last updated 26 Sept 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

Cardiac radioablation is a new treatment for ventricular tachycardia (VT), which uses beams of radiation to treat heart scar that causes VT. To identify the scar areas, magnetic resonance imaging (MRI) and computed tomography (CT) imaging are often used. These are both types of medical imaging that allow clinicians to examine scar area without having to do invasive surgery. Researchers have developed new heart imaging protocols using both MRI and CT. Their MRI protocol method can now spot both dense and scattered scar tissue. The CT protocol combines multiple different types of scans into a single appointment and uses a special scanner that captures the motion of the heart. For this study, patients will undergo CT and MRI imaging according to these new imaging protocols. With this study, researchers aim to show that these new imaging protocols can be undergone by patients with ventricular tachycardia and can be used to identify scar. Researchers will also use these scans to make radiation treatment plans to identify which types of treatment can be delivered safely to patients.

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
15 (estimated)
First submitted
7 Apr 2025
Start date
1 Nov 2025
Primary completion date
1 Jul 2026
Lead sponsor
Stewart Gaede
NCT number
NCT06938074

What you commit to

  • Study type: Interventional
  • Planned participants: 15
  • From 1 Nov 2025 to the primary completion date, 1 Jul 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Who the study is looking for

  • Ischemic cardiomyopathy with monomorphic VT
  • Referred by cardiologists
  • 18 years of age or older Exclusion Criteria
  • • Polymorphic ventricular tachycardia
  • Ventricular fibrillation
  • Pregnant or breastfeeding or planning to become pregnant or breastfeed during the study
  • Estimated glomerular filtration rate ≤ 30 mL/min/1.73m2
  • Previous allergic reaction to CT contrast agent Note that participants with contraindications for MRI can still be enrolled in this study but will not undergo MRI parts of this protocol.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
London Health Sciences Centre Research Inc.
Coordinator of this site? Confirm its status
LondonCanadaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.